These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Filling the void: urinary markers for bladder cancer risk and diagnosis. Gazdar AF; Czerniak B J Natl Cancer Inst; 2001 Mar; 93(6):413-5. PubMed ID: 11259458 [No Abstract] [Full Text] [Related]
44. URINARY LACTIC DEHYDROGENASE ACTIVITY. II. ELEVATED ACTIVITIES FOR THE DIAGNOSIS OF CARCINOMAS OF THE KIDNEY AND BLADDER. DORFMAN LE; AMADOR E; WACKER WE Biochem Clin; 1963; 2():41-55. PubMed ID: 14095811 [No Abstract] [Full Text] [Related]
45. Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? No (a difficult task). O'Brien T J Urol; 2013 Jul; 190(1):20-1. PubMed ID: 23602484 [No Abstract] [Full Text] [Related]
46. PRIMARY TUMOURS OF THE URETER: REPORT OF 17 CASES. JOENSSON G Acta Chir Scand; 1963 Oct; 126():368-78. PubMed ID: 14070612 [No Abstract] [Full Text] [Related]
47. Classification and staging of bladder carcinoma. Prout GR Cancer; 1980 Apr; 45(7 Suppl):1832-41. PubMed ID: 7370934 [No Abstract] [Full Text] [Related]
50. [PERIVESICAL CO2-INSUFFLATION COMBINED WITH DOUBLE CONTRAST-MEDIUM CYSTOGRAPHY IN THE DIAGNOSIS OF BLADDER TUMORS]. KELEMEN J; HORVATH G Magy Radiol; 1963 Sep; 15():273-6. PubMed ID: 14093012 [No Abstract] [Full Text] [Related]
51. A PRELIMINARY REPORT OF A NEW METHOD FOR THE STAGING OF BLADDER CARCINOMA USING A TRIPLE CONTRAST TECHNIQUE. TAYLOR DA; MACKEN KL; VEENEMA RJ; BACHMAN AL Br J Radiol; 1965 Sep; 38():667-72. PubMed ID: 14331603 [No Abstract] [Full Text] [Related]
52. Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity? Herr HW; Al-Ahmadie H; Dalbagni G; Reuter VE BJU Int; 2010 Nov; 106(10):1499-501. PubMed ID: 20346034 [TBL] [Abstract][Full Text] [Related]
53. Carcinoma in situ of the bladder. Utz DC; Farrow GM; Rife CC; Segura JW; Zincke H Cancer; 1980 Apr; 45(7 Suppl):1842-8. PubMed ID: 7370935 [No Abstract] [Full Text] [Related]
54. Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy. Pagliarulo V; Alba S; Gallone MF; Di Stasi S; Cormio L; Petitti T; Buscarini M; Minafra P; Carrieri G J Endourol; 2017 Apr; 31(4):405-411. PubMed ID: 28145751 [TBL] [Abstract][Full Text] [Related]
55. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745 [TBL] [Abstract][Full Text] [Related]
56. SALIVARY GLAND TUMORS. THEIR EARLY DIAGNOSIS AND TREATMENT. NELSON WR; DAVIS WM Rocky Mt Med J; 1964 May; 61():27-32. PubMed ID: 14153101 [No Abstract] [Full Text] [Related]
57. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses. Garbar C; Mascaux C; Wespes E Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491 [TBL] [Abstract][Full Text] [Related]
58. HEMATURIA: A SIGN OF URINARY TRACT NEOPLASM. GRAF RA J Iowa Med Soc; 1964 Apr; 54():179-84. PubMed ID: 14139565 [No Abstract] [Full Text] [Related]
59. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies. Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596 [TBL] [Abstract][Full Text] [Related]